Showing 5,805 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

Data sets up 2021 filings for Gilead's twice-a-year HIV drug lenacapavir

Editor's pick
Pharmaphorum
20 November 2020
Injectable & long-acting HIV treatment

A Long-Lasting, More Effective HIV Drug Is A Psychological Relief For Patients

Editor's pick
NPR
20 November 2020
New & experimental HIV treatments

Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV

Editor's pick
Gilead press release
20 November 2020
Treatment outcomes & life expectancy

H.I.V. Death Rates Fell by Half 2010-2018, C.D.C. Says

Editor's pick
New York Times
20 November 2020
Treatment outcomes & life expectancy

Millions of people are on treatment for HIV: why are so many still dying?

Editor's pick
The Conversation
18 November 2020
HIV testing programmes & uptake

Almost half of HIV diagnoses in Europe are late, with serious impact on health outcomes

News
18 November 2020
HIV treatment for children & young people

New neonatal liquid formulations of dolutegravir have comparable bioavailability to dispersible paediatric tablet

Editor's pick
i-Base
16 November 2020
Improving HIV care

Escalate HIV Adherence Strategies Amid COVID-19

Editor's pick
Medscape (requires free registration)
16 November 2020
Weight gain & lipodystrophy

Women Show Higher INSTI-Associated Weight Gain and Incident Diabetes Mellitus Than Men

Editor's pick
Infectious Disease Advisor
12 November 2020
Hepatitis & HIV

European HIV doctors conduct their first-ever region-wide audit of services

News
11 November 2020
Weight gain & lipodystrophy

Diabetes drug may aid weight loss in people with HIV

News
6 November 2020
Injectable & long-acting HIV treatment

Long-acting injectables appear feasible for long-term HIV treatment

News
4 November 2020
The search for a cure

Could a multiple sclerosis medication be used against the HIV reservoir?

News
2 November 2020
New & experimental HIV treatments

Monoclonal antibody ibalizumab maintains HIV suppression for nearly a decade

News
29 October 2020
Weight gain & lipodystrophy

More Research Points to Weight Increases on TAF-Containing HIV Treatment

Editor's pick
TheBodyPro
27 October 2020
Injectable & long-acting HIV treatment

Similar benefits and barriers to injectables for HIV prevention and treatment reported by US women

News
21 October 2020
Drug interactions & pharmacokinetics

Study finds diabetes is associated with a 25% reduction in concentration of tenofovir in blood spot samples, but what are the causes and consequences?

News
20 October 2020
Changing treatment

Switching HIV Regimen to Biktarvy Is Safe and Effective for the Long Term

Editor's pick
POZ
19 October 2020
Treatment guidelines

Perinatal Exposure to HIV Requires Specialized, Coordinated Care

Editor's pick
American Journal of Managed Care
19 October 2020
Injectable & long-acting HIV treatment

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

Editor's pick
ViiV Healthcare press release
16 October 2020
Clinical trials

Biological, clinical and ethical imperatives for involving diverse women in HIV clinical trials

News
14 October 2020
Resistance

Multidrug Resistance Still Boosts Death Risk in 31,000-Person Italian Study

Editor's pick
NATAP
13 October 2020
Injectable & long-acting HIV treatment

New once-a-week drug could be part of weekly oral treatment

News
13 October 2020
People with limited treatment options

Patients with HIV and four-class drug resistance have high disease burden

Editor's pick
Healio
11 October 2020